Krsnaa Diagnostics Share Price Today (KRSNAA)
Today’s Krsnaa Stock Read
Krsnaa Diagnostics is trading up 0.13% at ₹538.25. With a market cap of ₹1,753.8 Cr, it trades at a P/E of 17.29. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
Krsnaa Diagnostics is trading up 0.13% at ₹538.25. With a market cap of ₹1,753.8 Cr, it trades at a P/E of 17.29. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
Krsnaa Diagnostics Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Krsnaa Diagnostics Limited, framed against the sector median so the premium or discount is obvious at a glance.
Krsnaa Diagnostics Limited trades at a P/E of 17.29× and P/B of 1.79×.
Valuation
Profitability
Growth
Financial Health
Krsnaa Diagnostics Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Krsnaa Diagnostics Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Krsnaa Diagnostics Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Krsnaa Diagnostics Limited, switchable between annual and quarterly views, consolidated or standalone.
Krsnaa Diagnostics Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,753.8 Cr and reported EPS of ₹30.86.
| Period | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue from Operations | 455 | 487 | 620 | 717 | 773 |
| Other Income | 15 | 19 | 17 | 26 | 43 |
| Total Income | 470 | 507 | 636 | 743 | 816 |
| Cost of Goods Sold (COGS) | 60 | 74 | 141 | 169 | 179 |
| Gross Profit | 395 | 413 | 479 | 548 | 594 |
| +Operating Expenses | 264 | 291 | 334 | 358 | 382 |
| EBITDA | 131 | 122 | 144 | 190 | 212 |
| +Non-Operating Expenses | 60 | 61 | 91 | 113 | 125 |
| Profit Before Tax (PBT) | 87 | 80 | 70 | 103 | 130 |
| +Tax Expense | 18 | 18 | 13 | 25 | 29 |
| Total Profit for Period | 68 | 62 | 57 | 78 | 101 |
| Net Profit (Owner's PAT) | 68 | 62 | 57 | 78 | 101 |
| Earnings Per Share (EPS) | 21.78 | 19.78 | 17.60 | 24.03 | 31.27 |
| Diluted Shares Outstanding (Nos.) | 3 | 3 | 3 | 3 | 3 |
| +Additional Disclosures | 444 | 501 | 707 | 810 | 865 |
| Sales Growth % | — | 6.95 | 27.20 | 15.74 | 7.75 |
| YoY Sales Growth % | — | 6.95 | 27.20 | 15.74 | 7.75 |
| Material Cost % | 13 | 15 | 23 | 24 | 23 |
| Employee Cost % | 12 | 15 | 18 | 19 | 18 |
| Other Cost % | 46 | 44 | 36 | 31 | 31 |
| OPM % | 29 | 25 | 23 | 27 | 27 |
| Tax % | 21 | 23 | 19 | 24 | 22 |
| Profit Growth % | — | -9.18 | -8.49 | 36.54 | 30.70 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| +Additional Fields | 90 | 69 | 70 | 102 | 121 |
Krsnaa Diagnostics segment analysis: revenue and profit mix.
Disclosed business segments at Krsnaa Diagnostics with their share of revenue and profit, switchable between consolidated and standalone reporting.
Krsnaa Diagnostics discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Krsnaa Diagnostics Limited.
Our AI distills the core fundamental drivers supporting Krsnaa Diagnostics Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
Krsnaa Diagnostics Limited's investment case rests on 7 positive markers and 8 flagged concerns drawn from the latest reported filings.
What you're getting.
Krsnaa Diagnostics shows robust quarterly sales growth of 13.40% and profit growth of 14.50%, indicating strong operational efficiency and increasing market demand for its diagnostic services.
The company maintains a healthy operating profit margin (OPM) of 26.90%, reflecting effective cost management and strong pricing power in the competitive healthcare sector. This is supported by an 8.76% Return on Equity.
Krsnaa Diagnostics maintains a very healthy debt-to-equity ratio of 0.23, indicating a low reliance on borrowed capital and strong financial stability, which is favorable for long-term growth.
Operating in the growing healthcare service provider sector, Krsnaa is well-positioned to capitalize on increasing healthcare expenditure and rising demand for diagnostic services across India.
The expanding healthcare sector and rising demand for diagnostic services in India present significant growth avenues for Krsnaa, allowing for market penetration and service expansion.
What can break it.
Promoter holding is relatively low at 27.11% (as of 2025-09-01), which could raise concerns about management control or potential future dilution, potentially impacting long-term investor confidence.
The company's price-to-book value of 2.89 suggests the market prices Krsnaa Diagnostics at a premium to its net asset value, potentially indicating high investor expectations or a degree of overvaluation.
Recent five-day stock price movements show volatility, with daily changes ranging from -2.15% to +0.22%, indicating market uncertainty and potential risk for short-term investors.
FII and DII holdings have shown a declining trend, with DIIs decreasing from 27.36% to 14.96% since 2022-06, while public holding increased to 54.27%, which may signal institutional caution.
The diagnostic services industry is highly competitive, with established players and new entrants potentially leading to pricing pressures and market share erosion for Krsnaa Diagnostics.
What would change my mind.
Trim if P/E re-rates above 22. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.04. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Krsnaa Diagnostics Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Krsnaa Diagnostics Limited is highlighted for quick read-across.
Quick Compare
Krsnaa Diagnostics Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Krsnaa Diagnostics Limited — derived from the live tape, not yesterday's close.
Krsnaa Diagnostics Limited last traded at ₹538.25 with an intraday range of ₹534–₹543.05 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹538.25| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 560.97 | +22.72 | +4.22% |
| R3 | 551.92 | +13.67 | +2.54% |
| R2 | 547.48 | +9.23 | +1.72% |
| R1 | 542.87 | +4.62 | +0.86% |
| PIVOT | 538.43 | 0.18 | 0.03% |
| CURRENT | 538.25 | — | — |
| S1 | 515.72 | -22.53 | -4.19% |
| S2 | 524.77 | -13.48 | -2.51% |
| S3 | 529.38 | -8.87 | -1.65% |
| S4 | 533.82 | -4.43 | -0.82% |
KRSNAA is trading Below CPR, indicating Bearishness
CPR is Narrower, suggesting likely for trending moves
Day's range: 536.25 ~ 539.75
Trading Inside opening range
Krsnaa Diagnostics Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Krsnaa Diagnostics Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Krsnaa Diagnostics Limited stood at 61.3% of traded volume, against a 20-day average of 57.4%.
Krsnaa Diagnostics announcements: results, concalls, ratings, M&A.
Filings Krsnaa Diagnostics sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Krsnaa Diagnostics files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 151 documents below.
Copy of Newspaper Publication
Krsnaa Diagnostics Limited has informed the Exchange about Copy of Newspaper Publication
Shareholders meeting
Krsnaa Diagnostics Limited has informed the Exchange regarding Notice of Postal Ballot
Disclosure under SEBI Takeover Regulations
KRSNA Diagnostics (Mumbai) Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange…
General Updates
Krsnaa Diagnostics Limited has informed the Exchange about General Updates
Analysts/Institutional Investor Meet/Con. Call Updates
Krsnaa Diagnostics Limited has informed the Exchange about Link of Recording
Investor decks & rating reports.
Investor Presentation
Updates
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Krsnaa Diagnostics insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Krsnaa Diagnostics as reported to SEBI — buying and selling signals from the people who know the business best.
Krsnaa Diagnostics insider activity below tracks 1 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Krsna Diagnostics (Mumbai) Private Limited | Insider | 27 Dec 2024 | buy | +22.9 K | ₹2 Cr | ₹870.89 |
Krsnaa Diagnostics dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Krsnaa Diagnostics has declared, sequenced by announce and record date.
Krsnaa Diagnostics corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Krsnaa Diagnostics Limited: business, sector, key facts.
What Krsnaa Diagnostics Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Krsnaa Diagnostics Limited operates in the Healthcare Service Provider industry under the Healthcare sector, listed as NSE: KRSNAA, BSE: 543328.
Krsnaa Diagnostics Limited is a prominent provider of diagnostic services across India, specializing in a comprehensive range of medical testing and imaging solutions. Their service portfolio encompasses a wide spectrum of diagnostic modalities, catering to the diverse needs of both individual patients and institutional clients. This diverse offering positions them as a significant player in the Indian healthcare landscape.
The company's core services fall under three major categories: radiology, pathology, and teleradiology. Radiology services likely encompass various imaging techniques such as X-rays, CT scans, MRIs, and ultrasound, providing detailed anatomical images for diagnosis. Pathology services involve the analysis of bodily fluids and tissues to detect diseases and abnormalities at a cellular level. Teleradiology, a crucial aspect of their offerings, allows for the remote interpretation of medical images, enabling the efficient dissemination of diagnostic expertise across geographically dispersed areas and improving access to specialist opinion.
Beyond individual tests, Krsnaa Diagnostics also offers a suite of pre-packaged health check-ups designed to assess specific health concerns or cater to particular demographics. These packages address common health issues, covering areas such as diabetes, heart health, liver function, kidney function, thyroid health, cancer risk assessment, and more. They also offer specialized packages targeting specific age groups, like senior citizen health checks, and address common conditions such as infections and fatigue. This targeted approach enhances accessibility and convenience for patients seeking preventative healthcare or focused diagnostic evaluations.
Krsnaa Diagnostics serves a broad client base, including public and private hospitals, medical colleges, and community health centers. This diverse clientele highlights their adaptability and significance within the healthcare ecosystem. Their reach across various healthcare sectors demonstrates their ability to meet the diagnostic needs of a wide range of patients and medical institutions. This widespread network positions them as a key contributor to the overall quality and accessibility of healthcare in India.
Established in 2010 and headquartered in Pune, India, Krsnaa Diagnostics has developed a strong presence within the country's diagnostic services sector. Their comprehensive service portfolio, coupled with their broad client base, positions them as a significant player in the Indian healthcare market, contributing to improved diagnostic capabilities and healthcare access across various segments of the population.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Health X Platform (HEALTHX) Share PricePeer
- Dr Lal Path Labs (LALPATHLAB) Share PricePeer
- Metropolis Healthcare (METROPOLIS) Share PricePeer
- Suraksha Diagnostic (SURAKSHA) Share PricePeer
- Thyrocare Technologies (THYROCARE) Share PricePeer
- Stocks near 52-week low (reversal watch)Screener
- Reversal Hunter strategy playbookStrategy
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Krsnaa Diagnostics Limited (KRSNAA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Krsnaa Diagnostics Limited (KRSNAA)?
The current share price of Krsnaa Diagnostics Limited (KRSNAA) is ₹538.25. Today, the stock has gained by ₹0.70 (0.13%), trading in a range of ₹534 to ₹543.05. The stock opened at ₹537.55 with a trading volume of 49,878 shares.
02Is Krsnaa Diagnostics Limited stock a good investment for long-term?
Krsnaa Diagnostics Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,753.8 crores, P/E ratio of 17.29, ROE of 10.89%, and ROCE of 11.90%. The dividend yield stands at 0.51%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Krsnaa Diagnostics Limited stock?
The 52-week high price of Krsnaa Diagnostics Limited (KRSNAA) is ₹894.4, while the 52-week low is ₹515. Currently trading at ₹538.25, the stock is 6.1% away from its 52-week low and 39.8% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Krsnaa Diagnostics Limited stock at the current price?
Whether to buy Krsnaa Diagnostics Limited stock at ₹538.25 depends on multiple factors. The stock is currently trading with a P/E ratio of 17.29 and P/B ratio of 1.79. Today's performance shows a gain of 0.13%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Krsnaa Diagnostics Limited and when is the next dividend?
Krsnaa Diagnostics Limited offers a dividend yield of 0.51%, which means for every ₹100 invested at the current price of ₹538.25, you can expect to receive approximately ₹0.51 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Krsnaa Diagnostics Limited?
Krsnaa Diagnostics Limited's key financial metrics include: P/E Ratio: 17.29, P/B Ratio: 1.79, ROE: 10.89%, ROCE: 11.90%, Dividend Yield: 0.51%, EPS: ₹30.86, Book Value: ₹302.22, and Debt-to-Equity: 0.55. The company's market cap stands at ₹1,753.8 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Krsnaa Diagnostics Limited stock performing today in the market?
Krsnaa Diagnostics Limited stock opened at ₹537.55 and is currently trading at ₹538.25, showing a gain of ₹0.70 (0.13%). The intraday high is ₹543.05 and low is ₹534. The trading volume stands at 49,878 shares, indicating moderate market participation today.
08What is the P/E ratio of Krsnaa Diagnostics Limited and what does it indicate?
Krsnaa Diagnostics Limited has a Price-to-Earnings (P/E) ratio of 17.29, which means investors are willing to pay ₹17.29 for every ₹1 of earnings. With an EPS of ₹30.86, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Krsnaa Diagnostics Limited (KRSNAA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.